In this article, we will look at the 13 Most Promising Future Stocks to Buy Now.

On February 6, Josh Belton, Gabelli Funds portfolio manager for growth equities, appeared on CNBC’s ‘Squawk Box’ to talk about the latest market trends, his perspective on where AI is generating revenue in today’s market, and the effects of AI on software. He stated that the market has an “interesting irony” at present, with fears regarding AI being a bubble and AI investments not generating returns looming. At the same time, AI is clearly generating returns in certain areas today, including digital advertising, digital commerce, and cloud computing, with agentic software also becoming a strong contender. According to him, we can’t have it both ways: AI is either a bubble or it is eating software and other industries.

He added that, case by case, there are certainly examples of stocks that got way overextended on a valuation basis and have been coming back down to earth, even before last month. According to Belton, we have been in a couple of months of market rotation out of winners into laggards.

READ ALSO: 12 Most Undervalued Travel Stocks To Buy According To Hedge Funds and 10 Best Confectionery, Cookie and Snack Stocks To Buy. 

Talking about how one can figure out which stocks have been overextended and which actually earned it and are going to continue growing, he was of the opinion that a lot of the software companies were probably overvalued overall if we rewind 6, 12, and especially 18 months ago, with the hindsight being 2020. This was relative to fundamentals that were starting to decelerate and the disruption risk that was starting to percolate.

On the flip side, a lot of the large tech platforms, the ones that are benefiting from AI and see less obvious AI disruption risks, are trading at pretty reasonable valuation multiples today. Belton, however, added that valuation is not an investment thesis in and of itself, so these multiples can always de-rate further or start to rerate. While that is always hard to call, he feels “pretty comfortable” with where the large tech companies are trading currently.

With these trends in view, let’s look at the most promising future stocks to buy now.

Our Methodology

We sifted through financial media reports and next generation technology ETFs to find the best future stocks with high upside potential. We then chose the top 13 with the highest number of hedge fund holders, as of Q3 2025, sourcing the hedge fund sentiment data from Insider Monkey’s database. The list is sorted in ascending order of hedge fund holders.

Note: All data was recorded on February 6.

​Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 427.7% since May 2014, beating its benchmark by 264 percentage points (see more details here).

13 Most Promising Future Stocks to Buy Now

13. BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)

Number of Hedge Fund Holders: 54

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is one of the most promising future stocks to buy now. Piper Sandler revised the price target on BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) to $84 from $122 on February 6 and maintained an Overweight rating on the shares.

In another development, Barclays assumed coverage of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) with an Overweight rating and an $80 price target on January 27. The firm initiated coverage of 12 biotech stocks, assuming coverage of 11 with an optimistic outlook for the industry. Barclays stated that it likes the setup for the group in 2026, and anticipates “significant tailwinds” in the year, such as continued mergers and acquisitions, a reduced focus on drug pricing, and “strong” underlying fundamentals.

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) also received a rating update from Canaccord Genuity on January 20, with the firm upgrading it to Buy from Hold and adjusting the price target from $98 to $84. Canaccord believes the pending acquisition of Amicus to be the key catalyst that breaks BioMarin Pharmaceutical Inc.’s (NASDAQ:BMRN) shares out of the recent trading range, expecting that positive pipeline and commercial updates “could more meaningfully and durably shift sentiment” once the deal closes. This may help close the company’s “valuation gap”, according to the firm.

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) develops and commercializes therapies for serious and life-threatening medical conditions and rare diseases. The company’s product pipeline includes Valoctocogene roxaparvovec, Vosoritide, and BMN 307. It pursues bold science to translate genetic discoveries into new medicines, advancing the future of human health.

12. Okta, Inc. (NASDAQ:OKTA)

Number of Hedge Fund Holders: 55

Okta, Inc. (NASDAQ:OKTA) is one of the most promising future stocks to buy now. On February 5, Okta, Inc. (NASDAQ:OKTA) announced an expanded relationship with the PGA of America, enabling the latter to secure its network of golf professionals, employees, and fans. The PGA of America is one of the largest sports organizations across the globe, with over 30,000 PGA of America golf professionals nationwide. Management reported that both organizations will explore innovative ways to deliver and secure an AI-powered digital experience, building upon their existing technology relationship.

Okta, Inc. (NASDAQ:OKTA) further stated that it delivers the resilience and scalability essential to support the PGA of America Members at every digital touchpoint. The expanded relationship combines this with advanced protections against AI risks, allowing the PGA of America to offer seamless and secure access while bringing manual IT and development efforts down.

Shannon Duffy, Chief Marketing Officer at Okta, Inc. (NASDAQ:OKTA), stated that Okta, Inc. (NASDAQ:OKTA) secures AI, and thus the expanded relationship would allow the PGA to safely deploy next-generation AI experiences, strengthening engagement across the game while protecting its members. Duffy added:

“With Okta Platform as the unified identity layer and Auth0 Platform to defend the login against emerging risks, we help ensure that every AI agent interaction remains verified and grounded in trust”.

Okta, Inc. (NASDAQ:OKTA) provides an identity management platform for enterprises, operating through the International and United States geographical segments. The company secures the identity of every AI agent across its full lifecycle, irrespective of the task and environment. Its products include multi-factor authentication, single sign-on, API access management, access gateway, authentication, lifecycle management, and more.